Takara Bio Overview
- Year Founded
-
2002
- Status
-
Acquired/Merged
- Employees
-
1,743
- Latest Deal Type
-
M&A
- Financing Rounds
-
2
- Investments
-
9
Takara Bio General Information
Description
Developer of biotechnology products designed to support life science research and drug discovery. The company offers restriction enzymes, pcr reagents, scientific instruments, cdmo services, cell culture media, and gene therapy candidates, enabling pharmaceutical companies and academic institutions to advance regenerative medicine and genetic analysis.
Contact Information
Website
www.takara-bio.co.jp(Operating Subsidiary)
Corporate Office
- 4-38, Noji-Higashi 7-chome
- Kusatsu City, Shiga Prefecture 525-0058
- Japan
Corporate Office
- 4-38, Noji-Higashi 7-chome
- Kusatsu City, Shiga Prefecture 525-0058
- Japan
Takara Bio Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Takara Bio Comparisons
Industry
Financing
Details
Takara Bio Competitors (70)
One of Takara Bio’s 70 competitors is GeneTex, a Formerly VC-backed company based in Irvine, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| GeneTex | Formerly VC-backed | Irvine, CA | ||||
| CD Genomics | Corporation | Shirley, NY | ||||
| Novogene | Formerly PE-Backed | Beijing, China | ||||
| Genetix Biotherapeutics | Private Equity-Backed | Somerville, MA | ||||
| Abcam | Corporate Backed or Acquired | Cambridge, United Kingdom |
Takara Bio Patents
Takara Bio Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026141547-A1 | Optimization of 3'ltr upstream sequence in lentiviral vector | Pending | 26-Dec-2024 | ||
| WO-2026089040-A1 | Rna polymerase mutant | Pending | 25-Oct-2024 | ||
| WO-2025205770-A1 | Recombinant plasmid containing stuffer dna | Pending | 26-Mar-2024 | ||
| WO-2025164636-A1 | Rna-capping enzyme derived from faustovirus s17 | Pending | 30-Jan-2024 | ||
| EP-4825963-A1 | Rna polymerase variant and rna synthesis | Pending | 12-Dec-2023 | C12N9/1247 |
Takara Bio Signals
Takara Bio Investments & Acquisitions (9)
Takara Bio’s most recent deal was a Merger/Acquisition with ViSpot. The deal was made on 01-May-2025.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| ViSpot | 01-May-2025 | Merger/Acquisition | Laboratory Services (Healthcare) | ||
| StemCells (Stem Cell-related Research Products) | 11-Nov-2014 | Corporate Asset Purchase | Buildings and Property | ||
| Cellectis bioresearch (Sweden) | 04-Sep-2014 | Merger/Acquisition | Biotechnology | ||
| DSS Takara Bio India | 01-Jan-2011 | Joint Venture | Discovery Tools (Healthcare) | ||
| Nanosphere | 26-Apr-2006 | Later Stage VC | Diagnostic Equipment |
Takara Bio Exits (4)
Takara Bio’s most recent exit was on 26-Apr-2006 from Nanosphere. The exit was categorized as with 4 buyers.
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| Nanosphere | 26-Apr-2006 | Completed |
|
||
| Helixmith | 23-Feb-2005 | Completed |
|
||
| Nanosphere | 26-Nov-2002 | Completed |
|
||
| Helixmith | 01-Mar-2000 | Corporate | Completed |
Takara Bio Affiliates
Subsidiaries (3)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Cellectis bioresearch (Sweden) | Gothenburg, Sweden | 2001 | |
| Takara Bio Europe | Saint-Germain-En-Laye, France | 1995 | |
| Takara Bio (GMP Cell Processing Contract Business) | Kusatsu, Japan |
Takara Bio FAQs
-
When was Takara Bio founded?
Takara Bio was founded in 2002.
-
Where is Takara Bio headquartered?
Takara Bio is headquartered in Kusatsu City, Japan.
-
What is the size of Takara Bio?
Takara Bio has 1,743 total employees.
-
What industry is Takara Bio in?
Takara Bio’s primary industry is Biotechnology.
-
Is Takara Bio a private or public company?
Takara Bio is a Private company.
-
What is the current valuation of Takara Bio?
The current valuation of Takara Bio is .
-
What is Takara Bio’s current revenue?
The current revenue for Takara Bio is .
-
How much funding has Takara Bio raised over time?
Takara Bio has raised $77M.
-
Who are Takara Bio’s competitors?
GeneTex, CD Genomics, Novogene, Genetix Biotherapeutics, and Abcam are some of the 70 competitors of Takara Bio.
-
When was Takara Bio acquired?
Takara Bio was acquired on 10-Apr-2026.
-
Who acquired Takara Bio?
Takara Bio was acquired by Takara Holdings.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process